FDA Inspection 1150253 — UC Reproductive Medicine at Kettering

UC Reproductive Medicine at Kettering — FEI 3003928248

The FDA completed an inspection of UC Reproductive Medicine at Kettering on August 25, 2021 in Kettering, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 25, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Kettering, OH (United States)